Ginseng PLANTAS MEDICINALES Hyun SH, Kim SW, Seo HW, Youn SH, Kyung JS, Lee YY et al. Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng. Journal of Ginseng Research. 2020; 44: 527-37. Kang N, Gao H, He L, Liu Y, Fan H, Xua Q et al. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71. J. Ethnopharmacol. 2021; 266: 113401. Lemmon HR, Sham J, Chau LA, Madrenas J. High molecular weight polysaccharides are key immunomodulators in North American ginseng extracts: Characterization of the ginseng genetic signature in primary human immune cells. J. Ethnopharmacol. 2012; 142: 1-13. Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S et al. Anticancer property of ginsenoside Rh2 from ginseng. Eur J Med Chem. 2020; 203: 112627. Liu D, Liu T, Teng Y, Chen W, Zhao L, Li X. Ginsenoside Rb1 inhibits hypoxia-induced epithelial mesenchymal transition in ovarian cancer cells by regulating microRNA-25. Exper. Ther. Med. 2017; 14(4): 2895-902. Liu L, Xu FR, Wang YZ. Traditional uses, chemical diversity and biological activities of Panax L. (Araliaceae): A review. J Ethnopharmacol. 2020; 263: 112792. Liu W, Zheng Y, Han L, Wang H, Saito M, Ling M et al. Saponins (Ginsenosides) from stems and leaves of Panax quinquefolium prevented high-fat diet-induced obesity in mice. Phytomedicine. 2008; 15(12):1140-5. Liu Y, Zhang H, Dai X, Zhu R, Chen B, Xia B et al. A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng. Phytomedicine. 2021; 92: 153717. Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms [retracted in: Evid Based Complement Alternat Med. 2020 24; 2020: 1698627]. Evid Based Complement Alternat Med. 2009; 6(4): 423-27. Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: from pharmacology to toxicology. Food Chem. Toxicol. 2017; 107: 362-72. •Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021; 45(2): 199-210. Razgonova MP, Veselov VV, Zakharenko AM, Golokhvast KS, Nosyrev AE, Cravotto G et al. Panax ginseng components and the pathogenesis of Alzheimer’s disease (Review). Mol Med Rep. 2019; 19(4): 2975-98. Sun C, Chen Y, Li X, Tai G, Fan Y, Zhou Y. Anti-hyperglycemic and anti-oxidative activities of ginseng polysaccharides in STZ-induced diabetic mice. Food Funct. 2014; 5(5): 845-8. Szczuka D, Nowak A, Zakłos-Szyda M, Kochan E, Szymańska G, Motyl I et al. American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties. Nutrients. 2019; 11(5): 1041. Tam DNH, Truong DH, Nguyen TTH, Quynh LN, Tran L, Nguyen HD et al. Ginsenoside Rh1: A Systematic Review of Its Pharmacological Properties. Planta Med. 2018; (84): 139-152. Tsai CC, Chan P, Chen LJ, Chang CK, Liu Z, Lin JW. Merit of ginseng in the treatment of heart failure in type 1-like diabetic rats. Biomed Res Int. 2014; 2014: 484161. Villar AM, Naval MV, Gómez-Serranillos MP. Ginseng. Farmacia Profesional. 2003; 17(10): 68-73. Vinh LB, Park JU, Duy LX, Nguyet NTM, Yang SY, Kim YR et al. Ginsenosides from Korean red ginseng modulate T cell function via the regulation of NF-AT-mediated IL-2 production. Food Sci Biotechnol. 2019; 28(1): 237-42. Yi YS. New mechanisms of ginseng saponin-mediated anti-inflammatory action via targeting canonical in ammasome signaling pathways. J. Ethnopharmacol. 2021; 278: 114292. Zhou P, Xie W, He S, Sun Y, Meng X, Sun G et al. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells. 2019; 8(3): 204. ai167414183838_AAFF-MEDYFAR-Gripe-Resfriado-210X148mm.pdf 1 19/01/2023 16:23:59
RkJQdWJsaXNoZXIy MTEwMTU=